Page results
-
Introduction of Bordetella pertussis PCR testing at Halo laboratory (Health Services Laboratories)
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
SUMMIT Study results on the benefits of large-scale screening for lung cancer are published in The Lancet Oncology today (26 March), ahead of the formal addition of lung cancer screening to the UK national screening programme from 1 April.
-
The North Central London Integrated Care System (NCL ICS) has new services and staff training to support patients with inherited red cell disorders, including Sickle Cell and Thalassaemia, living in Barnet, Camden, Enfield, Haringey and Islington.
-
This page provides details of your treatment pathway coordinator for the Teenage and Young Adult Cancer Service.
-
Dr. Patrick Murphy is a principal clinical neuropsychologist at the National Hospital for Neurology and Neurosurgery
-
The North Central London Integrated Care System (NCL ICS) has new services and staff training to support patients with inherited red cell disorders, including Sickle Cell and Thalassaemia, living in Barnet, Camden, Enfield, Haringey and Islington.
-
The video-assisted stroke triage project, developed by the UCLH stroke service in partnership London Ambulance Service (LAS) has won the HSJ Patient Safety Award for Clinical Governance & Risk Management in Patient Safety.
File results
-
FOI/2022/0781 - Protocols for diagnosis and treatment of non-small cell lung cancer
-
FOI/2022/0775 - Data on COVID-19 infections and related illness in staff
-
FOI/2022/0774 - Pre-pregnancy counselling clinics with consultant-led maternity units for women with medical problems
-
FOI/2022/0772 - Treatments for rare diseases
-
FOI/2022/0770 - Parking operations, impact, and parking charge notices issued
-
FOI/2022/0768 - Patients treated for Haemophila A
-
FOI/2022/0764 - Patients treated for drinks spiked/ spiked by needle injection
-
FOI/2022/0741 - Number of women in the maternity service identified as needing an interpreter
-
FOI2017161 Supplier and cost of patient food
-
FOI/2022/0739 - Treatment of HR+ adjuvant breast cancer